Jason Wan, PhD, is Co-Founder and Head of Product at Taudia, a precision proteomics startup developing ultra-sensitive blood-based biomarker tools to accelerate the detection and treatment of neurodegenerative diseases.

Jason earned his PhD in Biomedical Engineering from Georgia Institute of Technology, where he developed microfluidic tools to study aging, before launching his first commercial products at Thermo Fisher Scientific.

Driven by a passion for translating scientific ideas into impactful products, Jason brings deep expertise in biomedical engineering, microfluidics, and product development to the neuroscience diagnostics space.

Prior to Taudia, Jason held research and product roles at Thermo Fisher Scientific, the Wisconsin Institute for Discovery, Georgia Institute of Technology, and Invenra, building a strong foundation across industry and academia.

Taudia has secured venture backing from investors including IT-Farm, Endurance28, and NTU Ventures, and has partnered with the Global Alzheimer's Platform Foundation on the Bio-Hermes-002 study alongside industry leaders such as Biogen, Eli Lilly, and Roche.